News and Announcements
Tatau features in top media publications as a company simplifying the computational equation
- Published October 17, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- With the business of blockchain technology expected to reach $176 billion by 2025 platforms such as Tatau are becoming more popular.
- Technology giant IBM is the latest company to take an interest in the world of blockchain.
- Tatau has been featured in media giants, The Entrepreneur and ZeroHedge.
The business value of blockchain technology is expected to reach $176 billion by 2025 and, in the next 2 decades this figure is predicted to rise to $3.1 trillion.
Technology giant IBM is the latest company to take an interest in the world of blockchain.
Tatau is a blockchain-based distributed platform, that allows anyone to buy and sell computational capacity on decentralized, GPU-based machines
Co-founder of Tatau, Andrew Fraser said that IBM’s success ‘will be partnerships with other innovators which will help accelerate their developments and minimize risk.’
According to ZeroHedge, Tatau is simplifying the computational equation by creating a blockchain platform that provides better computing capacity.
Tatau offers a service which allows people who have GPU-based machines to rent them to the company. The Entrepreneur describes Tatau as ‘the platform pools together GPU power from renters for companies and projects to use in running their own complex computational requirements.’
About Tatau.io
Tatau is a blockchain-based distributed platform, that allows anyone to buy and sell computational capacity on decentralized, GPU-based machines. Tatau is helping meet the growing demand for computational power required for complex computations in verticals such as AI/deep learning, video rendering, and predictive analytics.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
